Botulinum A chemodenervation: a new modality in cerebral palsied hands

Area of Science:

• Neurology
• Orthopedics
• Rehabilitation Medicine

Background:

• Thumb-in-palm deformity is a common challenge in children with cerebral palsy (C.P.), impacting hand function.
• Botulinum toxin type A (BoNT-A) is increasingly explored for spasticity management.

Purpose of the Study:

• To evaluate the efficacy of BoNT-A chemodenervation of the Adductor Pollicis muscle for treating thumb-in-palm deformity in hemiparetic C.P. hands.

Main Methods:

• A prospective, non-trialist-biased study assessed five children with hemiparetic C.P.
• Intervention involved BoNT-A injection into the Adductor Pollicis muscle.
• Assessment used independent panel review of photographic/video records, grip dynamometry, and goniometry.

Main Results:

• All participants demonstrated improvements in hand function and appearance.
• Results approached statistical significance (p=0.06) using Wilcoxon's matched-pairs signed rank test.
• The treatment was simple, safe, and effective over a 229-day follow-up period.

Conclusions:

• BoNT-A chemodenervation of the Adductor Pollicis is a promising therapeutic option for thumb-in-palm deformity in C.P.
• Benefits extended beyond the period of induced muscle paresis.
• Long-term follow-up is necessary to determine optimal retreatment timing.